Finn RS, Crown J, Lang I, et al. Overall survival results from the randomized phase II study of palbociclib (P) in combination with letrozole (L) vs letrozole alone for frontline treatment of ER+/HER2– advanced breast cancer (PALOMA-1; TRIO-18). J Clin Oncol. 35, 2017 (suppl; abstr 1001).
Hoge dosis chemotherapie niet beter dan chemoradiotherapie bij ewingsarcoom met longmetastasen
dec 2019 | Longoncologie, Radiotherapie